Loading clinical trials...
Loading clinical trials...
ACCELERATE a Multisite Prospective Hybrid (Effectiveness-implementation) Type 2 Design, Single-arm, Mixed-methods Study of a Simplified Accelerated ART Initiation Protocol for People With HIV Who Are Out of Care.
Conditions
Interventions
The Accelerate model of care
bictegravir/emtricitabine/tenofovir alafenamide 50/200/25 mg
Locations
4
United States
University of Missouri-Columbia
Columbia, Missouri, United States
KC Care Health Center
Kansas City, Missouri, United States
AIDS Project of the Ozarks
Springfield, Missouri, United States
NOVUS Health
St Louis, Missouri, United States
Start Date
April 29, 2024
Primary Completion Date
May 1, 2026
Completion Date
November 1, 2026
Last Updated
April 20, 2025
NCT07486960
NCT07083011
NCT06755697
NCT07037459
NCT07123194
NCT00024479
Lead Sponsor
University of Missouri-Columbia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions